Structure and antigenicity of the 2026 Bundibugyo virus glycoprotein
It is found that several glycan cap-, GP base-, and HR2-directed antibodies cross-reacted and neutralized BDBV DRC/2026 GP pseudovirus with potency comparable to that observed against earlier BDBV isolates and the Zaire ebolavirus Makona/2024 isolate.